Related Experiment Video

Updated: Jun 30, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

[Tumour stem cells in glioma--tomorrow's therapeutic target?]

Karina Christensen1, Henrik Daa Schrøder, Bjarne Winther Kristensen

  • 1Odense Universitetshospital, Afdeling for Klinisk Patologi, Odense C. karina.christensen@ouh.regionsyddanmark.dk

Ugeskrift for Laeger
|September 24, 2008
PubMed

Insights

Brain tumour stem cells drive glioma resistance to therapy. Targeting these specific cells offers a promising strategy to inhibit brain tumour growth and improve treatment outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Stem Cell Biology
  • Tumor Microenvironment

Context:

  • Gliomas remain a significant cause of cancer-related mortality despite extensive research.
  • The identification of brain tumour stem cells (BTSCs) has revolutionized understanding of glioma biology.
  • BTSCs are increasingly implicated in therapeutic resistance and tumor recurrence.

Purpose:

  • To review the brain tumour stem cell paradigm in gliomas.
  • To highlight key characteristics of BTSCs.
  • To elucidate the role of BTSCs in resistance to radiation and chemotherapy.

Summary:

  • Brain tumour stem cells (BTSCs) are a critical subpopulation within gliomas.
  • These cells exhibit unique characteristics that contribute to their resistance to conventional treatments.
  • Targeting BTSCs presents a viable therapeutic strategy to overcome treatment resistance and inhibit tumor progression.

Impact:

  • This review provides a focused overview of BTSCs and their role in glioma treatment resistance.
  • It emphasizes the potential of targeting BTSCs for developing more effective glioma therapies.
  • Understanding BTSC biology is crucial for advancing neuro-oncology and improving patient survival rates.

More Related Videos

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...